JP2016512501A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512501A5
JP2016512501A5 JP2016500869A JP2016500869A JP2016512501A5 JP 2016512501 A5 JP2016512501 A5 JP 2016512501A5 JP 2016500869 A JP2016500869 A JP 2016500869A JP 2016500869 A JP2016500869 A JP 2016500869A JP 2016512501 A5 JP2016512501 A5 JP 2016512501A5
Authority
JP
Japan
Prior art keywords
butoxy
tert
alkyl
acetic acid
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500869A
Other languages
English (en)
Japanese (ja)
Other versions
JP6268656B2 (ja
JP2016512501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/021867 external-priority patent/WO2014159076A1/en
Publication of JP2016512501A publication Critical patent/JP2016512501A/ja
Publication of JP2016512501A5 publication Critical patent/JP2016512501A5/ja
Application granted granted Critical
Publication of JP6268656B2 publication Critical patent/JP6268656B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500869A 2013-03-14 2014-03-07 ヒト免疫不全ウイルス複製の阻害剤 Expired - Fee Related JP6268656B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361781315P 2013-03-14 2013-03-14
US61/781,315 2013-03-14
PCT/US2014/021867 WO2014159076A1 (en) 2013-03-14 2014-03-07 Inhibitors of human immunodeficiency virus replication

Publications (3)

Publication Number Publication Date
JP2016512501A JP2016512501A (ja) 2016-04-28
JP2016512501A5 true JP2016512501A5 (enExample) 2017-03-09
JP6268656B2 JP6268656B2 (ja) 2018-01-31

Family

ID=50439486

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016500869A Expired - Fee Related JP6268656B2 (ja) 2013-03-14 2014-03-07 ヒト免疫不全ウイルス複製の阻害剤

Country Status (5)

Country Link
US (1) US9540393B2 (enExample)
EP (1) EP2970297A1 (enExample)
JP (1) JP6268656B2 (enExample)
CN (1) CN105008369B (enExample)
WO (1) WO2014159076A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015123182A1 (en) * 2014-02-12 2015-08-20 Bristol-Myers Squibb Company Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
US9409922B2 (en) 2014-02-18 2016-08-09 Bristol-Myers Squibb Company Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
US9273067B2 (en) 2014-02-19 2016-03-01 Bristol-Myers Squibb Company Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
CN116005285B (zh) * 2022-12-26 2025-03-25 广东蒙泰高新纤维股份有限公司 一种抗紫外回收餐盒聚丙烯纤维的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939545B2 (en) 2006-05-16 2011-05-10 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
US7985753B2 (en) 2006-08-04 2011-07-26 Merz Pharma Gmbh & Co. Kgaa Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators
HRP20120328T2 (hr) 2007-11-15 2012-09-30 Gilead Sciences Inhibitori replikacije virusa humane imunodeficijencije
EP2574610A1 (en) 2007-11-15 2013-04-03 Gilead Sciences, Inc. Inhibitors of human immonodeficiency virus replication
CA2705338A1 (en) 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
WO2009062285A1 (en) 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
EP2215298B1 (en) 2007-11-23 2014-03-26 Koninklijke Philips N.V. Compartment
TW200942243A (en) * 2008-03-05 2009-10-16 Biocryst Pharm Inc Antiviral therapeutic agents
US8129398B2 (en) * 2008-03-19 2012-03-06 Bristol-Myers Squibb Company HIV integrase inhibitors
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
US8338441B2 (en) 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
KR101483834B1 (ko) 2009-12-23 2015-01-16 카트호리이케 유니버시타이트 로이펜 항바이러스 화합물
AP2013006706A0 (en) 2010-07-02 2013-02-28 Gilead Sciences Inc Napht-2-ylacetic acid derivatives to treat AIDS
PH12013500015A1 (en) 2010-07-02 2013-02-18 Gilead Sciences Inc 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
US8633200B2 (en) * 2010-09-08 2014-01-21 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
BR112013011737A2 (pt) 2010-11-15 2016-08-09 Univ Leuven Kath composto, uso de um composto composição farmacêutica, e, método de tratamento ou prevenção de uma infecção por hiv
CN103429595B (zh) 2010-11-15 2015-10-21 Viiv保健英国有限公司 Hiv复制的抑制剂
JP5997763B2 (ja) * 2011-05-19 2016-09-28 フンダシオン セントロ ナシオナル デ インベスティガシオネス オンコロヒカス カルロス ザ サードＦｕｎｄａｃｉｏｎ Ｃｅｎｔｒｏ Ｎａｃｉｏｎａｌ ｄｅ Ｉｎｖｅｓｔｉｇａｃｉｏｎｅｓ Ｏｎｃｏｌｏｇｉｃａｓ Ｃａｒｌｏｓ ＩＩＩ タンパク質キナーゼ阻害剤としての大環状化合物
US8791108B2 (en) * 2011-08-18 2014-07-29 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
US8906929B2 (en) * 2012-08-16 2014-12-09 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication

Similar Documents

Publication Publication Date Title
PH12021500049A1 (en) 2,3-dihydroquinazolin compounds as nav1.8 inhibitors
JP2015524841A5 (enExample)
JP2016512507A5 (enExample)
JP2016516692A5 (enExample)
JP2013531029A5 (enExample)
HRP20241553T1 (hr) 4-(4-(4-(((2-(2,6-dioksopiperidin-3-il)-l-oksoizoindolin-4-il)oksi)metil)benzil)piperazin-l-il)-3-fluorobenzonitril kao antiproliferativni spoj
JP2016535795A5 (enExample)
JP2016512511A5 (enExample)
JP2016506961A5 (enExample)
SI3024819T1 (en) Glyoxamide-substituted pyrrolamide derivatives and their use as medicines for the treatment of hepatitis B
JP2016506962A5 (enExample)
JP2016528301A5 (enExample)
NZ708593A (en) Novel pyrazole derivative
JP2018522927A5 (enExample)
JP2017537949A5 (enExample)
MX2020001717A (es) Inhibidores macrociclicos de mcl-1 y metodos de uso.
JP2020507589A5 (enExample)
UA115881C2 (uk) Алкоксипіразоли як активатори розчинної гуанілатциклази
GEAP202215588A (en) N-substituted-dioxocyclobutenylamino-3-hydroxypicolinamides useful as ccr6 inhibitors
JP2017526748A5 (enExample)
IL257240A (en) History of 5– (n– benzyl tetrahydroisoquinoline – 6 – il) Pyridine – 3 – il Acetic acid as inhibitors of human immunodeficiency virus replication
MX2023009388A (es) Metodos para tratar alteraciones del comportamiento.
RU2017107715A (ru) Производные имидазо[1,2-a]пиридина для применения в качестве ингибиторов репликации вируса иммунодефицита человека
RU2016142611A (ru) Пролекарственные средства ингибиторов обратной транскриптазы вич
RU2018106498A (ru) Производные 5-(N-конденсированный трициклический арил-тетрагидроизохинолин-6-ил) пиридин-3-ил-уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека